Bausch Execs Escape Derivative Suit Over Fraud Scheme
By Katryna Perera ( September 20, 2021, 7:19 PM EDT) -- A New Jersey federal judge on Monday adopted a recommendation to dismiss a shareholder derivative class action that alleged executives of Canadian pharmaceutical company Bausch Health Cos. Inc. tried to cover up a price-gouging scheme....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.